Literature DB >> 8479027

Peyronie's plaque: surgical treatment with the carbon dioxide laser and a deep dorsal vein patch graft.

G R Fournier1, T F Lue, E A Tanagho.   

Abstract

We describe a procedure for ablation of Peyronie's plaque using the carbon dioxide laser, which allows one to remove all palpable evidence of plaque while at the same time avoiding the creation of a large defect in the tunica albuginea requiring coverage with a large graft. The plaque is removed by making either a longitudinal or transverse incision in the plaque with a focused carbon dioxide laser beam from a hand held probe, and evaporating the plaque substance from the undersurface by tangentially directing the laser beam. It is possible to remove large dystrophic calcifications from within the plaque and to augment the repair in the area of greatest curvature using the deep dorsal vein as a patch graft. In cases of narrow plaques relaxation incisions and venous patch grafting alone are usually sufficient to correct the deformity. Our experience with 12 patients is summarized and 2 cases are reported in detail to illustrate the versatility of the procedure.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8479027     DOI: 10.1016/s0022-5347(17)36382-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  Peyronie's disease. Investigation of staging, erectile failure and operative management.

Authors:  S Kümmerling; J Schubert
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

2.  Patient-partner satisfaction with intracavernous medication supported with oral agents in selected cases of Peyronie's disease. A ten-month follow-up study.

Authors:  M Culha; N Mutlu; O Acar; B Alici
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

3.  Excision and Patch Grafting of a Lateral Peyronie's Plaque-Utilizing a Longitudinal "Window" Approach.

Authors:  Kathy Lue; Justin B Emtage; Daniel R Martinez; Christopher Yang; Rafael Carrion
Journal:  Sex Med       Date:  2015-06       Impact factor: 2.491

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.